Tag: Over-the-Counter Drugs and Devices

Displaying 1 - 20 of 103 results.

Pages

Filtering by content type: Federal Register Notice

Filtering by content type: Public Statement

Filtering by content type: Press Release

Note: The FTC will host a media call-in on this announcement with Andrew Smith, Director, Bureau of Consumer ProtectionDate: Thursday, December 17, 202Time: 11:00 a.m. ETCall-in: 844-291-6360; Access Code: 389969Call-in lines, which are for media only, will open 15 minutes prior to the start of the...
The Federal Trade Commission is sending checks totaling $774,755 to 13,221 consumers who bought Synovia, a supplement advertised and sold by A.S. Research, LLC as a treatment for arthritis and joint pain. The average refund amount is $58.60 per consumer.
The Federal Trade Commission announced it has sent letters warning 20 more marketers nationwide to stop making unsubstantiated claims that their products and therapies can prevent or treat COVID-19, the disease caused by the novel coronavirus. This is the ninth set of warning letters the FTC has...
The Federal Trade Commission is sending 4,782 checks totaling $76,368.54 to consumers who bought Isoprex, a supposed “miracle” pain supplement marketed to older Americans nationwide.
The Federal Trade Commission is sending 12,219 checks totaling more than $110,000 to consumers who bought StimTein, a pill that would supposedly provide effective joint pain relief.
The Federal Trade Commission is sending 70,142 checks and PayPal payments totaling $3,864,824 to consumers nationwide who bought Quell, a wearable device that supposedly would treat chronic pain throughout the body when placed below the knee.
The Federal Trade Commission announced it has sent letters warning 20 more marketers nationwide to stop making unsubstantiated claims that their products and therapies can prevent or treat COVID-19, the disease caused by the novel coronavirus. This is the eighth set of warning letters the FTC has...
The Federal Trade Commission charged a California-based company called Golden Sunrise Nutraceutical, Inc. with deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19, the disease caused by coronavirus.

Filtering by content type: Case

In December 2020, the FTC announced its first law enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products. The Commission took action against six sellers of CBD-containing products for allegedly making a wide range of scientifically unsupported...
In December 2020, the FTC announced its first law enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products. The Commission took action against six sellers of CBD-containing products for allegedly making a wide range of scientifically unsupported...
In December 2020, the FTC announced its first law enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products. The Commission took action against six sellers of CBD-containing products for allegedly making a wide range of scientifically unsupported...
The Federal Trade Commission filed suit against American Screening for failing to deliver on promises that it could quickly ship products like face masks, sanitizer, and other personal protective equipment (PPE) related to the coronavirus pandemic.The lawsuits allege that the...
The Federal Trade Commission filed suit against Zaappaaz, the operators of wrist-band.com and other online storefronts, for failing to deliver on promises that they could quickly ship products like face masks, sanitizer, and other personal protective equipment (PPE) related to the...

Pages